Hereditary ovarian carcinomas: clinico-biological features and treatment

被引：4
|
作者：
Floquet, Anne [1 ]
Stoeckle, Eberhard [2 ]
Croce, Sabrina [3 ]
Longy, Michel [4 ]
Mc Grogan, Gaetan [3 ]
Barouk, Emmanuelle [4 ]
Bubien, Virginie [4 ]
Garbay, Delphine [1 ]
Joly, Eglantine [4 ]
Guyon, Frederic [2 ]
机构：
[1] Inst Bergonie, Dept Med Oncol, F-33076 Bordeaux, France
[2] Inst Bergonie, Dept Chirurg, F-33076 Bordeaux, France
[3] Inst Bergonie, Dept Anatomopathol, F-33076 Bordeaux, France
[4] Inst Bergonie, Unite Oncogenet, F-33076 Bordeaux, France
来源：
BULLETIN DU CANCER | 2014年 / 101卷 / 02期
关键词：
hereditary ovarian cancer; hereditary breast ovarian cancer; Lynch syndrom; Parp inhibitors; EPITHELIAL OVARIAN; BRCA2; MUTATIONS; POLYMERASE INHIBITOR; CANCER; SURVIVAL; WOMEN; RESISTANCE; OLAPARIB; THERAPY; BREAST;
D O I：
10.1684/bdc.2014.1888
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hereditary ovarian cancers account for 10% of all cases. Two major syndromes with dominant autosomal transmission are identified. The most common one is breast-ovarian cancer syndrome due to BRCA1 and BRCA2 genes mutations, and the Lynch syndrome with mutated MMR genes is the other. Alterations in homologous recombination specifically observed in ovarian cancer with BRCA defects associated to Parp inhibition create a synthetic lethality of special interest. Numerous studies are in progress to explore this promising new approach. Furthermore, it seems that carcinogenesis of these two syndromes are different, suggesting alternative therapeutic options in the near future in order to improve prognosis of ovarian carcinomas.
引用
收藏
页码：167 / 174
页数：8
相关论文
共 50 条
  • [31] IMMUNOPHENOTYPIC CHARACTERISTICS OF BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA - CORRELATIONS WITH CLINICO-BIOLOGICAL FEATURES AND SURVIVAL
    URBANOISPIZUA, A
    CERVANTES, F
    MATUTES, E
    VILLAMOR, N
    PUJADES, A
    SIERRA, J
    FELIU, E
    VIVESCORRONS, JL
    MONTSERRAT, E
    ROZMAN, C
    LEUKEMIA, 1993, 7 (09) : 1349 - 1354
  • [32] FREGAT: French clinico-biological database dedicated to esogastric cancers
    Renaud, Florence
    Bibeau, Frederic
    Leteurtre, Emmanuelle
    Delaeter, Christine
    Dib, Malek
    Harter, Valentin
    Adenis, Antoine
    Piessen, Guillaume
    Mariette, Christophe
    ANNALES DE PATHOLOGIE, 2017, 37 (06) : 457 - 466
  • [33] In vitro growth in acute myeloblastic leukemia:: Clinico-biological correlations
    Del Cañizo, C
    Galende, J
    Almeida, J
    Brufau, A
    Mota, A
    San Miguel, JF
    LEUKEMIA & LYMPHOMA, 1999, 36 (1-2) : 1 - 7
  • [34] Clinico-biological characteristics of flow cytometry applied to hypersensitivity to NSAIDs
    J. Sainte-Laudy
    F. Touraine
    A. Boumediene
    F. Bonnaud
    M. Cogné
    Inflammation Research, 2007, 56 : S63 - S64
  • [35] EPIDEMIOLOGIC AND CLINICO-BIOLOGICAL ASPECTS OF URINARY LITHIASIS IN ALGERIAN CHILDREN
    BENALLEGUE, S
    BOUBEKEUR, Z
    BOUZID, A
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : A72 - A72
  • [36] CLINICO-BIOLOGICAL PROFILE OF RHEUMATOID ARTHRITIS WITH PERIODONTITIS AND PORPHYROMONAS GINGIVALIS
    Mechid, Farida
    Hafirassou, Houda
    Meddad, Malika
    Salah, Samir
    Merad, Saida
    Blidi, Nawel
    Makhloufi-Dahou, Chafia
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1585 - 1585
  • [37] HER2 guided neoadjuvant treatment of advanced breast cancer: Clinico-biological correlations
    Crivellari, D.
    Miolo, G.
    Lombardi, D.
    Massarut, S.
    Perin, T.
    Venturini, S.
    Di Lauro, V.
    Dolcetti, R.
    Tumolo, S.
    Veronesi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Incidence of cytogenetic abnormalities and DNA aneuploidy in multiple myeloma. Associations with clinico-biological features of patients.
    Collado, R
    Sanchez, H
    Cabeuo, AI
    Navarro, I
    Ferrer, R
    Ruiz, MA
    Martinez, J
    Otero, M
    Mora, C
    Hueso, J
    Miguel-Sosa, A
    Carbonell, F
    BLOOD, 2002, 100 (11) : 368B - 368B
  • [39] The clinico-biological features of a B-CLL variant, defined according to a combined cytofluorimetric/fish diagnostic approach
    Cro, L.
    Baldini, L.
    Zucal, N.
    Ferrario, A.
    Nobili, L.
    Neri, A.
    Lionetti, M.
    Bertoni, F.
    Morabito, F.
    Cutrona, G.
    Cortelezzi, A.
    Guffanti, A.
    Goldaniga, M.
    Luminari, S.
    Ferrarrini, M.
    Lambertenghi-Deliliers
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 112 - 112
  • [40] Clinico-biological Particularities of Silent Myocardial Ischemia in Type 2 Diabetics
    Hamine, Yousra
    Choukrani, Hanane
    Khalil, Maria
    Arous, Salim
    Habbal, Rachida
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142 : S34 - S35
12345